NVST Stock Overview
Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, and markets dental products in the United States and internationally.
Envista Holdings Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||US$40.08|
|52 Week High||US$46.52|
|52 Week Low||US$29.31|
|1 Month Change||2.51%|
|3 Month Change||-6.33%|
|1 Year Change||34.81%|
|3 Year Change||n/a|
|5 Year Change||n/a|
|Change since IPO||43.40%|
Recent News & Updates
Envista Holdings (NYSE:NVST) Is Experiencing Growth In Returns On Capital
If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...
Is Envista Holdings Corporation (NYSE:NVST) Potentially Undervalued?
Envista Holdings Corporation ( NYSE:NVST ), might not be a large cap stock, but it received a lot of attention from a...
|NVST||US Medical Equipment||US Market|
Return vs Industry: NVST exceeded the US Medical Equipment industry which returned 13.4% over the past year.
Return vs Market: NVST exceeded the US Market which returned 21.3% over the past year.
|NVST Average Weekly Movement||3.6%|
|Medical Equipment Industry Average Movement||7.2%|
|Market Average Movement||6.0%|
|10% most volatile stocks in US Market||15.0%|
|10% least volatile stocks in US Market||2.3%|
Stable Share Price: NVST is less volatile than 75% of US stocks over the past 3 months, typically moving +/- 4% a week.
Volatility Over Time: NVST's weekly volatility (4%) has been stable over the past year.
About the Company
Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, and markets dental products in the United States and internationally. The company operates in two segments, Specialty Products & Technologies and Equipment & Consumables. The company’s Specialty Products & Technologies segment provides dental implant systems, guided surgery systems, biomaterials, prefabricated and custom-built prosthetics, and dental eye loupes to oral surgeons, prosthodontists, and periodontists under the brands, including Nobel Biocare, Alpha Bio Tec, Implant Direct, Logon, Nobel Procera, and Orascoptic; and brackets and wires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products under the Damon, Ormco, Insignia, AOA, and Spark brands.
Envista Holdings Fundamentals Summary
|NVST fundamental statistics|
Is NVST overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|NVST income statement (TTM)|
|Cost of Revenue||US$1.25b|
Last Reported Earnings
Oct 01, 2021
Next Earnings Date
|Earnings per share (EPS)||1.88|
|Net Profit Margin||10.72%|
How did NVST perform over the long term?See historical performance and comparison
Is Envista Holdings undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: NVST ($40.08) is trading below our estimate of fair value ($44.64)
Significantly Below Fair Value: NVST is trading below fair value, but not by a significant amount.
Price To Earnings Ratio
PE vs Industry: NVST is good value based on its PE Ratio (21.4x) compared to the US Medical Equipment industry average (45.2x).
PE vs Market: NVST is poor value based on its PE Ratio (21.4x) compared to the US market (17.2x).
Price to Earnings Growth Ratio
PEG Ratio: NVST is poor value based on its PEG Ratio (2.7x)
Price to Book Ratio
PB vs Industry: NVST is good value based on its PB Ratio (1.6x) compared to the US Medical Equipment industry average (3.7x).
How is Envista Holdings forecast to perform in the next 1 to 3 years based on estimates from 11 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: NVST's forecast earnings growth (8% per year) is above the savings rate (2%).
Earnings vs Market: NVST's earnings (8% per year) are forecast to grow slower than the US market (14.3% per year).
High Growth Earnings: NVST's earnings are forecast to grow, but not significantly.
Revenue vs Market: NVST's revenue (4% per year) is forecast to grow slower than the US market (10.1% per year).
High Growth Revenue: NVST's revenue (4% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: NVST's Return on Equity is forecast to be low in 3 years time (8.3%).
How has Envista Holdings performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: NVST has a large one-off loss of $150.4M impacting its October 1 2021 financial results.
Growing Profit Margin: NVST's current net profit margins (10.7%) are higher than last year (0.4%).
Past Earnings Growth Analysis
Earnings Trend: NVST's earnings have declined by 16.8% per year over the past 5 years.
Accelerating Growth: NVST's earnings growth over the past year (3723%) exceeds its 5-year average (-16.8% per year).
Earnings vs Industry: NVST earnings growth over the past year (3723%) exceeded the Medical Equipment industry 51.2%.
Return on Equity
High ROE: NVST's Return on Equity (7.7%) is considered low.
How is Envista Holdings's financial position?
Financial Position Analysis
Short Term Liabilities: NVST's short term assets ($1.8B) exceed its short term liabilities ($1.3B).
Long Term Liabilities: NVST's short term assets ($1.8B) exceed its long term liabilities ($1.3B).
Debt to Equity History and Analysis
Debt Level: NVST's net debt to equity ratio (17.1%) is considered satisfactory.
Reducing Debt: Insufficient data to determine if NVST's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: NVST's debt is well covered by operating cash flow (31.9%).
Interest Coverage: NVST's interest payments on its debt are well covered by EBIT (7.3x coverage).
What is Envista Holdings's current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate NVST's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate NVST's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if NVST's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if NVST's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of NVST's dividend in 3 years as they are not forecast to pay a notable one for the US market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Amir Aghdaei (62 yo)
Mr. Amir Aghdaei has been President, Chief Executive Officer at Envista Holdings Corporation since September 20, 2019 and its Director since May 2019. Mr. Amir Aghdaei served as President and Group Execut...
CEO Compensation Analysis
Compensation vs Market: Amir's total compensation ($USD7.37M) is about average for companies of similar size in the US market ($USD6.24M).
Compensation vs Earnings: Amir's compensation has been consistent with company performance over the past year.
Experienced Management: NVST's management team is considered experienced (2.2 years average tenure).
Experienced Board: NVST's board of directors are not considered experienced ( 2.2 years average tenure), which suggests a new board.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Envista Holdings Corporation's employee growth, exchange listings and data sources
- Name: Envista Holdings Corporation
- Ticker: NVST
- Exchange: NYSE
- Founded: 2018
- Industry: Health Care Equipment
- Sector: Healthcare
- Market Cap: US$6.353b
- Shares outstanding: 161.37m
- Website: https://www.envistaco.com
Number of Employees
- Envista Holdings Corporation
- Building E
- 200 South Kraemer Boulevard
- United States
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/11/29 23:36|
|End of Day Share Price||2021/11/26 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.